SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Attention centers on the approaching FDA decision on Capricors deramiocel for Duchenne muscular dystrophy, with traders weighing the companys amended application and longer-term upper-limb data alongside recent FDA discussion of flexibility in rare-disease reviews. Many are bullish and read commercial hiring as a sign of launch preparation, while skeptics stress that approval is uncertain given the earlier negative review and debate over the evidence; some also cite Inovios separate FDA approval as a positive sentiment signal.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

A push to a fresh 52-week high is drawing attention ahead of an expected Q3 earnings update, while traders debate whether the rally reflects business momentum, short-covering, or speculation about an unconfirmed buyout.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

Inovios FDA approval of a competing RRP treatment has focused attention on the threat to Precigens PAPZIMEOS, its established therapy for the same condition. Traders are split on how much competition it poses, citing Precigens commercial head start and full approval versus Inovios potential treatment advantages and accelerated-approval requirements.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

A sharp selloff in gold has pushed GLD to a 52-week low, with traders citing persistent inflation and expectations of higher interest rates as pressure on precious metals. The drop has prompted debate over golds safe-haven role: some see broad liquidation and margin-call selling as temporary, while others expect further declines and are waiting for a clearer bottom.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovins steep selloff and fresh lows ahead of its earnings report are driving attention, with analyst price-target cuts and concerns about advertising demand adding pressure. Traders are split between viewing the decline as excessive given the companys growth and profitability, and worrying that weaker ad-market signals or an earnings disappointment could prolong the slide.

Okta, Inc. engages in the provision of an identity management platform for enterprises. The firm operates through the following geographical segments: United States and International. Its products include single sign-on, multi-factor authentication, access gateway, API access management, authentication, adaptive MFA and lifecycle management. The company was founded by Todd McKinnon and J. Frederic Kerrest in 2009 and is headquartered in San Francisco, CA.

Okta Inc - Ordinary Shares - Class A

Okta Inc

Oktas stronger-than-expected quarterly results and raised outlook, alongside growing interest in identity security for AI agents, have driven a sharp rally. Traders are divided between seeing durable cybersecurity demand and warning that the move has outrun the companys growth, with valuation concerns and profit-taking weighing on shares.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLASs Phase 3 REGAL leukemia trial reached its prespecified 80th death event, triggering final analysis ahead of topline results expected this quarter. Traders are divided over the binary readout: bulls view the trials duration and prior monitoring as encouraging, while bears stress that the treatment effect remains unknown and question the control-arm assumptions; the milestone has also coincided with selling despite bullish calls from some holders.

Mineralys Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing medicines to target diseases driven by abnormally elevated aldosterone. Its clinical-stage product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor that are initially developing for the treatment of cardiorenal conditions affected by abnormally elevated aldosterone, including hypertension and chronic kidney disease. The company was founded by Brian Taylor Slingsby on May 31, 2019 and is headquartered in Radnor, PA.

Mineralys Therapeutics Inc

MLYS is under pressure amid concerns that the slow early commercial ramp for AstraZenecas competing hypertension drug could signal a challenging launch and weaker near-term sales prospects for lorundrostat. Traders disagree on whether that undermines Mineralyss commercial outlook, with some emphasizing the upcoming FDA decision and clinical data while others question its ability to compete independently.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

A sharp tech-led selloff has focused attention on QQQ, with traders debating whether heavy AI infrastructure spending and uncertainty about its returns are weighing on tech stocks, alongside weakness in chipmakers. Views are split between expecting a relief bounce after an oversold drop and warning of further losses, amid volatile rebounds and heavy options trading.

FMC Corp. is an agricultural sciences company, which engages in the provision of solutions to growers and development of pipeline in crop protection, plant health, agriculture, pest control, and turf management. It offers insect control products under the Rynaxypyr and Cyazypyr brands. The company was founded by John Bean in 1883 and is headquartered in Philadelphia, PA.

FMC Corp.

FMCs quarterly update and recovery outlook are driving attention, with traders interpreting the restructuring reset as a possible sign that the worst is over and fueling talk of short covering. Others remain skeptical, citing weak demand, generic competition, heavy debt, and uncertainty about whether management can deliver the projected turnaround.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Gates Industrial (GTES) Q3 Earnings Top Estimates

Gates Industrial (GTES) delivered earnings and revenue surprises of +4.44% and -0.03%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

Illinois Tool Works (ITW) Surpasses Q3 Earnings Estimates

Illinois Tool Works (ITW) delivered earnings and revenue surprises of +0.33% and -0.59%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

Xometry CEO Sells 1,500 Shares Amid a 67% One-Year Return

Key PointsThe disposal involved 1,500 shares executed at a weighted average price of $85.23, representing a total transaction value of $127,845 on September 14, 2026...

Top 3D Printing Stocks to Buy for Solid Long-Term Returns

3D Printing is reshaping industries with faster production and lower costs, drawing investor interest. Stocks like ATI, NVDA, AVNT, PRLB and SNPS offer strong growth potential.

Xometry Director Sells 10,000 Shares

Key PointsThe transaction was valued at approximately $947,700...

Here's Why Xometry (XMTR) Could be Great Choice for a Bottom Fisher

After losing some value lately, a hammer chart pattern has been formed for Xometry (XMTR), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.

JPMorgan's Top Consumer Tech Picks: 5 Stocks It Likes Right Now

JPMorgan highlights five favorite consumer tech stocks: Shopify, Take-Two, Clear, Xometry and EverQuote, citing AI and long-term growth.read more...

All You Need to Know About Xometry (XMTR) Rating Upgrade to Buy

Xometry (XMTR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Top 3D Printing Stocks to Buy for Strong Long-Term Potential

3D Printing is reshaping industries with faster production and lower costs, drawing investor interest. Stocks like PRLB, SSYS, AME, ATRI and CRS offer strong growth potential.

Xometry (XMTR) Beats Q2 Earnings and Revenue Estimates

Xometry (XMTR) delivered earnings and revenue surprises of +33.33% and +6.38%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Xometry, Inc. offers an AI-powered marketplace, the popular Thomasnet industrial sourcing platform, and a suite of cloud-based services. Xometry's marketplaces use proprietary AI to help buyers efficiently source custom-manufactured parts and assemblies and attain instant pricing and lead times. The AI enables a rapidly growing network of manufacturers to select the optimal jobs to fill capacity. The firm's suite of cloud-based services and Thomasnet industrial sourcing platform help manufacturers and industrial service providers grow businesses using advertising, marketing, and financial services. It operates through the following geographical segments: the United States and International. The company was founded by Laurence Zuriff and Randolph Altschuler in 2013 and is headquartered in North Bethesda, MD.

Xometry Inc - Ordinary Shares - Class A

GOOGL, UBER, RDDT, XMTR Stocks Top Wedbush's Internet Picks – AI Called 'Single Most Impactful Swing Factor'

Equity

Bearish Sentiment

<ul class="summary-bullets"><li>Alphabet received Wedbush's highest-conviction mega-cap rating, with a $445 price target implying roughly 20% upside from Wednesday's close.</li><li>The firm’s price targets for Uber, Reddit, and Xometry each carried an implied upside of more than 25%.</li><li>Amazon and Instacart also earned 'Outperform' ratings, while Meta, DoorDash, and Pinterest were initiated with 'Neutral' ratings, reflecting more limited upside potential.</li></ul>Wedbush on Thursday named Alphabet (GOOGL), Uber (UBER), Reddit (RDDT), and Xometry (XMTR) its top internet stock picks across different market-cap categories, with analyst Ygal Arounian calling artificial intelligence (AI) the "single most impactful swing factor" shaping the sector's outlook.The firm stated that the companies with the “strongest combination of technology, product, and distribution” are best positioned to benefit as AI reshapes the internet industry.&nbsp;Wedbush's preferred names outperformed in pre-market trade, given that the Nasdaq-100 tracking&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust</a> (QQQ) fell 0.83% in premarket trading, while the&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF</a> (SPY) slipped 0.26%.<a href="https://stocktwits.com/symbol/GOOGL">GOOGL’s stock</a> and&nbsp;<a href="https://stocktwits.com/symbol/UBER">UBER shares</a> rose nearly 1% each.&nbsp;<a href="https://stocktwits.com/symbol/RDDT">RDDT stock</a> edged 0.25% higher, while&nbsp;<a href="https://stocktwits.com/symbol/XMTR">XMTR shares</a> traded flat.&nbsp;<h2 class="st-heading-2">The Big Three: Alphabet, Amazon, Meta</h2>Among the mega-cap internet names, Wedbush named Alphabet its top pick with an ‘Outperform' rating and a $445 price target, implying a potential 20% upside from Wednesday's close of around $370.Retail sentiment on Stockwits around GOOGL’s stock rose to ‘bullish’ from ‘bearish’ territory over the past day, accompanied by chatter at ‘normal’ levels. &nbsp;<figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_07_16_082327_png_7d39d455f3.webp" alt="Screenshot 2026-07-16 082327.png" width="1276" height="688"><figcaption>GOOGL stock retail sentiment on July 16 as of 8:15 a.m. ET | Source: Stocktwits&nbsp;</figcaption></figure>Amazon (AMZN) shares also received an ‘Outperform’ rating with a $293 price target, representing about 15% potential upside from a $254 closing price in the previous session.&nbsp;Meta Platforms (META) was the only mega-cap to receive a ‘Neutral’ rating. While Wedbush assigned a $671 price target, that sits below Wednesday's closing price of $681, implying limited near-term upside after the stock's strong rally.<a href="https://stocktwits.com/symbol/AMZN">AMZN’s stock</a> moved 0.6% higher in pre-market trade, while&nbsp;<a href="https://stocktwits.com/symbol/META">META’s stock</a> edged 0.14% higher. On Stockwits, retail sentiment around META remained in ‘bullish’ territory over the past day, while sentiment around AMZN improved to ‘bullish’ from the ‘neutral’ zone.<figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_07_16_082433_png_a20f13c373.webp" alt="Screenshot 2026-07-16 082433.png" width="1280" height="696"><figcaption>AMZN stock retail sentiment on July 16 as of 8:15 a.m. ET | Source: Stocktwits&nbsp;</figcaption></figure><h2 class="st-heading-2">Uber, Reddit, Xometry Lead Across Their Categories</h2>Wedbush selected Uber as its preferred large-cap internet stock, assigning an ‘Outperform’ rating and a $91 price target, implying approximately 27% upside from Wednesday's close of around $72.Instacart (CART) also earned an ‘Outperform’ rating with a $59 target, representing roughly 24% upside from Wednesday’s close of around $47. By comparison, DoorDash (DASH) received a ‘Neutral’ rating despite a $205 price target, leaving only about 8% upside from Wednesday's close of $190.&nbsp;<a href="https://stocktwits.com/symbol/DASH">DASH’s stock</a> edged 0.4% higher in pre-market trade, while&nbsp;<a href="https://stocktwits.com/symbol/CART">CART’s stock</a> traded flat.Retail sentiment around UBER and DASH on Stocktwits trended in ‘bearish’ territory over the past day, while sentiment around CART fell to ‘neutral’ from the ‘bullish’ zone.<figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_07_16_082611_png_6267e409af.webp" alt="Screenshot 2026-07-16 082611.png" width="1256" height="690"><figcaption>CART stock retail sentiment on July 16 as of 8:20 a.m. ET | Source: Stocktwits&nbsp;</figcaption></figure>Among social platforms, Reddit was Wedbush's top mid-cap pick. The firm assigned an ‘Outperform’ rating and a $250 target, implying about 26% upside from a closing price of $198 in the previous session. Pinterest, meanwhile, received a ‘Neutral’ rating with a $24 price target, reflecting far more modest expected gains than Reddit.For small-cap internet stocks, Wedbush named Xometry its preferred pick, initiating coverage with an ‘Outperform’ rating and a $126 price target, implying nearly 28% upside.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/atai-stock-soars-on-eli-lilly-s-2-8-b-buyout-why-cmps-shares-rising-too/cZZEJ7vR7sI">ATAI Stock Soars On Eli Lilly’s $2.8B Buyout – Why Are CMPS Shares Rising Too?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

A Google logo is displayed outside an office building on December 12, 2025 in San Diego, CA. (Photo by Kevin Carter/Getty Images)

Wedbush on Thursday named Alphabet (GOOGL), Uber (UBER), Reddit (RDDT), and Xometry (XMTR) its top internet stock picks across different market-cap categories, with analyst Ygal Arounian calling artificial intelligence (AI)

 Which Internet Stocks Could Benefit Most From AI? Wedbush Has Four Favorites

The Wall Street firm stated that companies with the strongest technology, products, and distribution are best positioned to benefit.


Alphabet Inc - Ordinary Shares - Class C

Alphabet Inc Class A

Reddit Inc

Uber Technologies Inc

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$93.65
Prev Close	$100.82
Open	$97.04
Dividend Yield	0.00%
50-Day Moving Average	$95.92
Beta	2.07
Avg. Volume	817,556.08
PE Ratio	-169.27

52-Week High	$112.94
52-Week Low	$35.86
Market Capitalization	$5.78B
EPS (Annual)	-$1.22
Price to Book	9.66
Revenue Per Employee	$584,864.57

Feed

News

Sentiment

Earnings

Fundamentals

Info

XMTR Fundamentals